期刊论文详细信息
Química Nova
Desafios da indústria farmacêutica brasileira
Angelo C. Pinto1  Eliezer J. Barreiro1 
[1] ,Instituto Nacional de Ciência e Tecnologia de Fármacos e MedicamentosRio de Janeiro RJ ,Brasil
关键词: Brazilian pharmaceutical industry;    generic medicines;    bottlenecks of the Brazilian pharmaceutical industry;   
DOI  :  10.1590/S0100-40422013001000012
来源: SciELO
PDF
【 摘 要 】

The paper traces a panorama of the development of new drugs and hopes to contribute for Brazil to become a player in the discovery of new drugs. Brazil is the sixth world market retail consumer of medicines prone to expansion, has a pharmaceutical industry focused on the production of generics and a very large number of undergraduate courses in Pharmacy. The national industry has grown over the last decade after the Generics Act 9787/99. Despite these positive aspects, a number of bottlenecks prevent Brazilian pharmaceutical industry to invest in the development of new drugs. There are, however, a number of initiatives to reduce the dependence on imported generic drugs. It is a very good start for the development of new pharmaceutical drugs.

【 授权许可】

CC BY-NC   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License

【 预 览 】
附件列表
Files Size Format View
RO202005130064407ZK.pdf 532KB PDF download
  文献评价指标  
  下载次数:5次 浏览次数:10次